Ryan Spencer - 10 Feb 2025 Form 4 Insider Report for DYNAVAX TECHNOLOGIES CORP (DVAX)

Role
CEO and Director, Director
Signature
/s/ Ryan Spencer
Issuer symbol
DVAX
Transactions as of
10 Feb 2025
Transactions value $
$-147,959
Form type
4
Filing time
12 Feb 2025, 17:01:07 UTC
Previous filing
19 Jul 2024
Next filing
18 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DVAX Common Stock Options Exercise +20,833 +10.3% 222,231 10 Feb 2025 Direct F1, F2
transaction DVAX Common Stock Tax liability $-147,959 -11,209 -5.04% $13.20 211,022 10 Feb 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DVAX Restricted Stock Unit Options Exercise -20,833 -100% 0 10 Feb 2025 Common Stock 20,833 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022.
F2 Includes 368 shares acquired under Issuer's 2014 Employee Stock Purchase Plan (ESPP) on August 15, 2024.
F3 Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.